Introduction
Numerous reports have documented that patients with vasculogenic impotence develop corpora cavernosal trabecular structural alternations. 1±3 Histopathologic and computer-assisted point counting technique with color histomorphometric studies as well as electron microscopic investigations have shown abnormal cavernosal smooth muscle cells with irregular contour of the cell wall, pleomorphic nuclei and sparse glycogen particles, aggregated mitochondria and decreased contractile elements in the cytoplasm. 4 It has also been reported that the severity of symptoms and clinical ®ndings in impotent men is proportional to the percentage of altered corporal smooth muscle cells. 5 Currently, sampling of the penile tissue is carried out at the time of penile prosthetic surgery. 5 Results of the biopsy, therefore can not contribute to the decision making and the treatment planning of impotence. Wespes has described a method of cavernous biopsy in the past. 6 We describe an improved technique of percutaneous core biopsy of the penis provides the opportunity to sample cavernosal tissue pre-operatively.
Materials and methods
This project was approved by our Institution Review Board (IRB). A non-selected group of patients who were undergoing dynamic infusion corpora cavernosography (DICC) for the work-up of impotence were offered biopsy. In ten patients, who agreed to sign the informed consent, biopsy was carried out. Patient's ages varied between 27 and 63 with an average of 51.2 y. One patient was diabetic. There was no other signi®cant medical history in any of the patients. In nine patients the biopsy was carried out immediately prior to DICC, in one it was done on a separate day.
Technique
Local anesthesia, 3 ml was used to anesthetize skin and subcutaneous tissue at the 2 o'clock position along the dorsal surface of the penile shaft immediately proximal to the region of corona of the glans penis.
A coaxial needle biopsy system was utilized. The system consisted of an automatic biopsy device (ABD) and two needles (Manan Medical Products, Northbook, IL); a 19 gauge (19 G) 3.8 cm long thin walled guiding needle through which a 20 gauge (20 G) 8 cm core biopsy needle was placed in the cavernosal tissue for biopsy passes. The length of the needles was such, when the ABD loaded with 20 G needle in cocked position was introduced through 19 G needle the tips of the two needles coincide with each other. As the ABD with 20 G needle the tip traveled for 12 mm with needle shaft containing an 8 mm specimen notch.
After placement of the guiding (19 G) needle into the cavernosal tissue via the anesthetized area, the glans penis was pulled and held ®rmly between the thumb and the index ®nger of the left hand. The trajectory of the 19 G needle was maintained parallel to the tunic albuginea along the sagittal plane of the penis. The cocked ABD loaded with 20 G needle was introduced through 19 G needle. A maximum of four specimens were obtained with different lengths of introduction of the guiding needle into the penile tissue. At the end of the procedure, local pressure on the penis was applied for 10 min and patient discharged home with pressure bandage to the penis.
Possible complications of local pain during biopsy, counter puncture of tunica albuginea or injury to the urethra was recorded. The patient was called on the phone to inquire about any complications the next day and was instructed to report to emergency department if hematoma or any other complications should occur.
The biopsy specimens were ®xed in 10% Formain of Bouin's¯uid and allowed to ®x overnight at 4 C. Paraf®n tissue blocks were prepared and cut in 3 m thick sections. Staining was performed for general histological analysis with hematoxylin and eosin or for trabecular smooth muscle (red) and connective tissue (blue) with Masson's trichrome. Using image analysis computer software (optimas 4.0 BioScan) color histomophometric evaluation was done to calculate the percentage of the trabecular smooth muscle to the total erectile tissue. 
Results
Biopsy specimens of cavernosal tissue were considered adequate in all 10 patients by the histopathologists for computer assisted color histomorphometric and immunohistochemical studies. No complications occurred. After the initial local anesthesia, no pain was experienced by any of the patients. No signi®cant hematoma, bleeding or deterioration of erectile function was observed or reported. As this is a report on the technique of percutaneous biopsy of the penis during DICC, no attempt was made to correlate the results of biopsy with other ®ndings in the work up of impotence.
Discussion
The relationship between the response to the penile vascular reconstructive surgery and the volume percentage of smooth muscle and the ®brous tissue contents of corpora cavernosa has been reported in the recent studies.
2,4,5 The presence of an excessive amount of ®brous tissue and loss of the smooth muscles seem to be related with reduced chances of surgical success.
4,5 It has been shown that patients with greater than 29% smooth muscle cells on cavernous biopsy responded well to penile venous surgery. 5 Coaxial approach of cavernosal biopsy provides opportunity to obtain several samples with a single puncture of the tunica albuginea. In nine of our patients the guiding biopsy needle was left in place for a subsequent diagnostic DICC study.
In cadavers, cavernosal tissue biopsy has been successfully performed using an automatic biopsy device. Wespes et al 6 reported biopsy of cavernous body with single pass of a biopsy needle using Biopty gun'. 6 In this report the information is not available as to the dimensions of the biopsy needle or whether the biopsy was performed in conjunction with DICC. We describe a technique of core biopsy of the penis that can be combined with DICC so that the need for a second penile puncture can be obviated by leaving the 19 G guiding needle in place for DICC. For a better tissue yield, the biopsy must be performed on a¯accid penis as much of the penile volume in an erect state consists of blood distended cavernosal lacunae. Vascular impotence is a diffuse penile disease. Therefore, cavernosal biopsy from one region of the penis would suf®ce to study the penile structure in the assessment of vascular impotence. 8, 9 If the smooth muscle to collagen tissue ratio is favorable on core biopsy, it may be possible to avoid surgery and patients managed by non-surgical means. In patients with, say, less than 29% smooth muscles in penile tissue, penile prosthetic surgery may be seriously considered. Besides, penile biopsy can be used as a research tool to assess the progression or regression of corporal ®brosis in patients after radical prostatectomy.
Conclusions
Core biopsy of the penis is a safe and substantially painless procedure that can provide clinically useful information in the work-up of erectile dysfunction and help make management decision particularly prior to penile implants surgery. 
Editorial comment
Percutaneous core biopsy of the penisÐby Sarwat Hussain et al
Hussain et al, in this issue, have provided us with a new variation on the issue of penile biopsy. In their report they show it is possible to obtain cavernous tissue that is adequate for evaluation from the same site as is used for subsequent DICC. Dr E Wespes has been the prime proponent of biopsy since his paper in 1990 documenting the feasibility of core biopsy 1 and his more recent analysis of biopsies in the mangement of men with veno-occlusive dysfunction. 2 It is clear that the penis provides the same opportunity for biopsy as it does for local injection: It is accessible and there are few complications.
Penile biopsy and cavernous tissue analysis promises to reveal the functional potential of cavernous tissue by identifying the percentage of ®brous tissue present. High percentages produce stiff cavernous tissue that expands poorly and either never achieves the in¯ow or the veno-occlusion that is needed for a rigid erection. This concept may be developed into a reliable way of proving that particular penile tissue is damaged beyond salvage so justifying, and documenting that justi®cation, the insertion of a prosthesis or the performance of a venous leak procedure.
Biopsy is a diagnostic test and should be subjected to the same evaluation as all diagnostic tests: Is it safe? Is it reproducable? Does it change management for the better? Is it cost effective? We cannot afford to embrace the new diagnostic tests that have the potential to be applied widely, just because they are simple, before they are independently validated.
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The real concern here is that the technique of biopsy is simple but the means of analysis is complex, involving as it does the use of several stains and computer aided image analysis. With the leadership of the authors above, and validated through outcome studies where the new information is used prospectively to direct therapy, we may see the introduction of biopsy as a regular component of the management of erectile dysfunction. However, until such time penile biopsy should remain in the hands of experts and in clinical trials and not become part of routine clinical management.
